Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
54,053,214
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
26,798,436
-
Shares change
-
-114,572
-
Total reported value, excl. options
-
$280,833,000
-
Value change
-
-$3,275,840
-
Number of buys
-
40
-
Number of sells
-
-27
-
Price
-
$10.48
Significant Holders of Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC) as of Q2 2021
77 filings reported holding FULC - Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q2 2021.
Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,798,436 shares
of 54,053,214 outstanding shares and own 49.58% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (5,962,202 shares), RTW INVESTMENTS, LP (3,205,291 shares), FMR LLC (2,379,481 shares), TRV GP IV, LLC (2,343,154 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1,627,444 shares), COWEN AND COMPANY, LLC (1,319,887 shares), BlackRock Inc. (1,297,445 shares), Casdin Capital, LLC (1,154,476 shares), VANGUARD GROUP INC (907,035 shares), and Alphabet Inc. (678,141 shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.